| [1] |
YANG Xiaofang, JIA Xinyan, FENG Wenjun.
MiR-181a-5p regulates the proliferation and apoptosis of glomerular mesangial cells in lupus nephritis mice through HMGB1/NF-κB signaling pathway
[J]. Tianjin Medical Journal, 2026, 54(3): 232-237.
|
| [2] |
LI Zhiwei, ZHANG Huichao, YANG Fengming, ZENG Chuiyi.
Exploring the effect of red ginseng total saponins on cardiomyocyte apoptosis in dilated cardiomyopathy mice based on miR-144-3p/MAPK1 pathway
[J]. Tianjin Medical Journal, 2026, 54(1): 23-29.
|
| [3] |
LIU Hong, ZHANG Yueyue, WANG Yilin, WANG Caili, WANG Xiaomin, MAO Min, LI Yan.
The research on the mechanism of microRNA-34a influencing the progression of chronic lymphocytic leukemia by regulating the Wnt pathway
[J]. Tianjin Medical Journal, 2025, 53(8): 785-790.
|
| [4] |
CUI Huan, GAO Ying, YANG Junjuan, GUO Ying, YE Qing.
Expression levels and clinical significance of miR-1227-3p and miR-212-3p in serum and placenta in puerperas with fetal growth restriction
[J]. Tianjin Medical Journal, 2025, 53(7): 709-713.
|
| [5] |
WU Bin, YANG Zigeng, JIN Ling, ZHANG Jing, WEI Hongmei, CAI Bingbing, WEI Yuying.
Effect of miRNA-381-3p/MuRF1 axis on cardiopulmonary injury in mice with hypoxic pulmonary hypertension
[J]. Tianjin Medical Journal, 2025, 53(6): 571-577.
|
| [6] |
ZHOU Meijuan, MIAO Xiaoxiang.
Relationship between serum expression levels of miR-214-3p and miR-124-3p and the severity of disease in patients with Parkinson's disease and their values in early diagnosis
[J]. Tianjin Medical Journal, 2025, 53(5): 498-502.
|
| [7] |
WANG Jian, CHENG Xianyong, YU Ning.
The impact of miR-1247-5p/Smad2 axis on gastric cancer cell migration, invasion and epithelial-to-mesenchymal transition
[J]. Tianjin Medical Journal, 2025, 53(2): 118-123.
|
| [8] |
SHENG Lanlan, OU Xiaofei.
The effect of LncRNA NNT-AS1 targeting miR-199a-5p on the proliferation, migration and invasion of oral squamous cell carcinoma cells
[J]. Tianjin Medical Journal, 2025, 53(11): 1131-1137.
|
| [9] |
PANG Zhihua, LIU Limei, YAO Zhuhua.
Research progress of biological functions of miR-101-3p in cardiovascular diseases
[J]. Tianjin Medical Journal, 2025, 53(11): 1223-1228.
|
| [10] |
HU Limei, LIU Huiying, CHEN Yaru, ZHAO Panpan, GU Jun, REN Weidong.
Clinical efficacy of caragliflozin and empagliflozin in obese patients with type 2 diabetes mellitus
[J]. Tianjin Medical Journal, 2025, 53(10): 1071-1076.
|
| [11] |
LI Peiyuan, WANG Gang, SHI Junfeng.
The expression of plasma lncRNA CEBPA-AS1 and miR-139-5p in patients with acute cerebral infarction and their correlation with cognitive dysfunction
[J]. Tianjin Medical Journal, 2025, 53(1): 75-79.
|
| [12] |
ZHANG Jinwei, WANG Yan, WANG Tong.
Effects of miR-107 on proliferation, invasion and migration of CAL27 cells in oral squamous cell carcinoma
[J]. Tianjin Medical Journal, 2024, 52(9): 897-899.
|
| [13] |
XIAO Xiaoli, XIE Yao, LONG Zhi.
Changes and clinical significance of serum miR-155 and miR-205-5p expression levels in patients with hepatitis C virus infection
[J]. Tianjin Medical Journal, 2024, 52(9): 967-970.
|
| [14] |
YAN Haifeng, WU Xiaohong, LIN Yuqing, HUO Kaiming, WANG Yingying.
Effect of miR-582-5p targeting regulation of FOXO1 on neuronal damage in neonatal rats with hypoxic ischemic encephalopathy
[J]. Tianjin Medical Journal, 2024, 52(4): 356-361.
|
| [15] |
XUE Wenping, QIN Wei, LIU Tingting, ZHANG Aiwen, SHI Fei.
Correlation between serum miR-34a and miR-182 levels before PCI and postoperative contrast-induced nephropathy occurrence in elderly patients with acute coronary syndrome
[J]. Tianjin Medical Journal, 2024, 52(4): 422-426.
|